JNJ dividend yield: 3.36%. MAIN dividend yield: 8.41%. Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices. Main Street Capital is a Business Development Company providing debt and equity capital to lower middle market companies. It pays regular monthly dividends plus semi-annual special dividends. One of the few BDCs consistently trading at a premium to NAV, with an exceptional track record since its 2007 IPO. Often called the gold standard of BDCs.
Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Main Street Capital is a Business Development Company providing debt and equity capital to lower middle market companies. It pays regular monthly dividends plus semi-annual special dividends. One of the few BDCs consistently trading at a premium to NAV, with an exceptional track record since its 2007 IPO. Often called the gold standard of BDCs.
Is JNJ or MAIN better for dividend income in 2026?
JNJ currently offers a 3.36% yield (4.96/share/year) while MAIN offers 8.41% (4.44/share/year). MAIN provides higher current income. However, JNJ has grown its dividend faster (5.8% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in JNJ vs MAIN earn per year?
With $10,000 invested today: JNJ pays approximately $336/year. MAIN pays approximately $841/year. With DRIP reinvestment over 10 years, these grow to $828/year (JNJ) and $2,355/year (MAIN).
Does JNJ or MAIN pay monthly dividends?
JNJ pays quarterly dividends. MAIN pays monthly dividends. MAIN pays monthly, which is preferred by investors who need regular cash flow.
📬
Get this JNJ vs MAIN comparison by email
Save your analysis + get weekly dividend insights. Free forever.